Despite the lower number of samples in which the NGF peak could be detected unambiguously (but not lower compared with the usual sample size commonly reported in the literature), we demonstrated that also NGF levels (similarly to proNGF levels) were significantly lower in AD samples compared with both controls and SMC subjects, while no significant difference was evident between SMC and controls. Here, NGF is linked to Alzheimer disease.